With New $65 Million Investment, Eko To Develop Its Home Telehealth Platform For People With Cardiopulmonary Disease

Eko, a cardiopulmonary digital health company that manufactures a digital stethoscope, today announced $65 million in Series C funding. Eko intends to use the new funding to expand in-clinic use of the company’s platform of telehealth and artificial intelligence (AI) algorithms for disease screening, and to launch a home monitoring program for people with cardiopulmonary disease.

The funding round was led by Highland Capital Partners and Questa Capital, with participation from Artis Ventures, DigiTx Partners, NTTVC, 3M Ventures, and other new and existing investors. As part of the investment, Corey Mulloy and Ryan Drant from Highland Capital Partners . . .